IMPLICATIONS OF CXCR3 EXPRESSION ON MYELOID CELLS FOR IMMUNOTHERAPY OF CANCER AND MYELOID-MEDIATED DISEASES
Technology
E-009-2023
Patent ID
E-009-2023-0-US-02
Country
US
Application Type
National Stage
Patent Status
Pending
Patent Number
Publication Number
Application Number
19/126,866
IC
NCI
Date Filed
Date Issued
Patent PDF